Series C startup

Who invested in Regend Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$51Mraised across 1 round since 2026, from 1 source

Latest round
Series C, $51MFeb 2026
Investors
1
See who backed them

The rounds

  1. Feb 2026
    Series C$51M

    Source recorded

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Regend Therapeutics

Who invested in Regend Therapeutics?

Regend Therapeutics's investors include Shenzhen Capital Group Co..

How much has Regend Therapeutics raised?

Regend Therapeutics has raised $51M across 1 round since 2026.

When did Regend Therapeutics last raise?

Regend Therapeutics's most recent round was a Series C of $51M in Feb 2026.

What was Regend Therapeutics's biggest round?

Its most recent round, $51M in Feb 2026, is also its largest on record.

Who backed Regend Therapeutics first?

Regend Therapeutics's first round on record, in Feb 2026, was backed by Shenzhen Capital Group Co..

What stage is Regend Therapeutics at?

Regend Therapeutics's latest named round is a Series C, in Feb 2026.

Companies like Regend Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.